Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China

Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China

Xiao Fan,1 Qi Li,2 Tingsong Li,3 Xiaoyan He,4 Chuan Feng,1 Bin Qin,1 Ye Xu,1 Ling He1 1Department of Radiology, the Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Dis...

Full description

Bibliographic Details
Main Authors:	Fan X, Li Q, Li T, He X, Feng C, Qin B, Xu Y, He L
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-08-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	myelin oligodendrocyte glycoprotein encephalomyelitis magnetic resonance imaging demyelination central nervous system
Online Access:	https://www.dovepress.com/radiological-features-for-outcomes-of-mogad-in-children-a-cohort-in-so-peer-reviewed-fulltext-article-NDT

Similar Items

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-04-01)

The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
by: Jie Xu, et al.
Published: (2021-05-01)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01)

The Wide Variety of Acute Disseminated Encephalomyelitis in Children: A Clinical Perspective
by: Hyunsuk Lim, et al.
Published: (2022-10-01)

Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
by: Jin Myoung Seok, et al.
Published: (2023-06-01)

Acute Hemorrhagic Encephalomyelitis in the Context of MOG Antibody-Associated Disease. Comment on Chen et al. Rapid Progressive Fatal Acute Hemorrhagic Encephalomyelitis. <i>Diagnostics</i> 2023, <i>13</i>, 2481
by: Sohyeon Kim, et al.
Published: (2023-10-01)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
by: Xueshan Dong, et al.
Published: (2023-05-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options
by: Yun-Jin Lee, et al.
Published: (2021-03-01)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
by: Patrick Peschl, et al.
Published: (2017-05-01)

The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children
by: Ünsal Yılmaz
Published: (2024-02-01)

Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry
by: Amanda Marchionatti, et al.
Published: (2021-05-01)

A case of anti-myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) associated disorder (MOGAD) with clinical manifestations of acute disseminated encephalomyelitis: Secondary to mycoplasma pneumoniae infection
by: Xiangui Huang, et al.
Published: (2023-02-01)

Recurrent myelin oligodendrocyte glycoprotein⁃IgG⁃associated optic neuritis⁃encephalomyelitis: one case report
by: Jing SHA, et al.
Published: (2020-10-01)

A Novel Lysolecithin Model for Visualizing Damage in vivo in the Larval Zebrafish Spinal Cord
by: Angela D. Morris, et al.
Published: (2021-05-01)

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery
by: Feng Mei, et al.
Published: (2016-09-01)

Generation of a murine model of chronic progressive Experimental Autoimmune Encephalomyelitis for molecular pharmacology studies in Multiple Sclerosis
by: Karelia Macías-Cosme, et al.

Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder
by: Yunjie Li, et al.
Published: (2022-09-01)

Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report
by: Jan Kolcava, et al.
Published: (2022-08-01)

Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
by: Sundararajan Jayaraman, et al.
Published: (2022-10-01)

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
by: Yoshiki Takai, et al.
Published: (2023-07-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as intractable fever managed by bromocriptine: a case report
by: Jin San Lee, et al.
Published: (2023-06-01)

A Rare Case Report: MOGAD with Optic Neuritis- without Spinal İnvolvement
by: Canan Akünal Türel, et al.
Published: (2023-04-01)

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature
by: Yangsa Du, et al.
Published: (2022-11-01)

The organization of microtubules and Tau in oligodendrocytes: Tau pathology in damaged oligodendrocytes
by: Tomohiro Torii, et al.
Published: (2022-10-01)

Diagnostic modalities in multiple sclerosis: Perspectives in children
by: I-Jun Chou, et al.
Published: (2014-04-01)

Delimiting MOGAD as a disease entity using translational imaging
by: Frederike Cosima Oertel, et al.
Published: (2023-12-01)

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
by: Maryam J. Tavaf, et al.
Published: (2023-01-01)

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
by: Kuniko Kohyama, et al.
Published: (2023-02-01)

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
by: Kerri Prain, et al.
Published: (2019-10-01)

Erratum: Delimiting MOGAD as a disease entity using translational imaging
by: Frontiers Production Office
Published: (2024-03-01)

Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Meifang Lei, et al.
Published: (2022-05-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
by: Leilei Mao, et al.
Published: (2019-08-01)

Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses
by: Dariush Haghmorad, et al.
Published: (2022-11-01)

The CNS Myelin Proteome: Deep Profile and Persistence After Post-mortem Delay
by: Olaf Jahn, et al.
Published: (2020-08-01)

Clinical Research into Central Nervous System Inflammatory Demyelinating Diseases Related to COVID-19 Vaccines
by: Mei-Yun Cheng, et al.
Published: (2024-03-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease as a novel presentation of central nervous system autoimmunity in a pediatric patient with Wiskott-Aldrich syndrome
by: Vivien X. Xie, et al.
Published: (2023-08-01)

Response Surface Methodology Approach to Optimize the Expression of Thioredoxin-MOG Fusion Protein
by: Maryam Radmard, et al.
Published: (2024-04-01)

Myelin oligodendrocyte glycoprotein encephalomyelitis: An unusual cause of blindness
by: Nimrat Sandhu, et al.
Published: (2022-01-01)

Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China
by: Jue Shen, et al.
Published: (2022-11-01)